Icariside E4
Product Specifications
CAS Number
126253-42-7
Target
AMPK, Liver X Receptor, Lipid, Fatty Acid Synthase, Potassium Channel, Antioxidant
Related Pathways
PI3K/Akt/mTOR signaling, Metabolism, Chromatin/Epigenetic, Oxidation-Reduction, Membrane transporter/Ion channel
Bioactivity
Icariside E4 is a natural compound derived from Ulmus minor that acts via AMPK phosphorylation and inhibition of MID1IP2 hypolipidation in HepG1 cells.Icariside E4 has anti-injurious, antioxidant, anti-Alzheimer's and anti-inflammatory effects and inhibits SREBP-1c, liver X receptor-α (LXR) and FASN in Icariside E4 is an effective candidate for the treatment of fatty liver disease and has hypolipidemic potential in HepG1 cells.
Smiles
C(O)[C@@H]1C=2C(O[C@H]1C3=CC(OC)=C(O[C@H]4[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O4)C=C3)=C(OC)C=C(CCCO)C2
Molecular Formula
C26H34O10
Molecular Weight
506.54
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP2-74883APC 0.1 mL
Mouse Monoclonal XPF Antibody (OTI4E11) [Allophycocyanin]
Sign In for Pricing
View Details 
K6181507 1.0 µg DNA
Sept12 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)
Sign In for Pricing
View Details 
043249-ML750 100 µL
TRIM5, CT (TRIM5, RNF88, Tripartite motif-containing protein 5, RING finger protein 88) (MaxLight 750) discontinued
Sign In for Pricing
View Details